Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck

NCT01538381 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

DRUG: Afatinib
OTHER: Observation

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]